SCGB3A1

Revision as of 14:32, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Secretoglobin, family 3A, member 1
Identifiers
Symbols SCGB3A1 ; HIN1; HIN-1; LU105; MGC87867; PnSP-2; UGRP2
External IDs Template:OMIM5 Template:MGI HomoloGene14160
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Secretoglobin, family 3A, member 1, also known as SCGB3A1, is a human gene.[1]


References

  1. "Entrez Gene: SCGB3A1 secretoglobin, family 3A, member 1".

Further reading

  • Krop IE, Sgroi D, Porter DA; et al. (2001). "HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells". Proc. Natl. Acad. Sci. U.S.A. 98 (17): 9796–801. doi:10.1073/pnas.171138398. PMID 11481438.
  • Porter D, Lahti-Domenici J, Torres-Arzayus M; et al. (2003). "Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues". Mech. Dev. 114 (1–2): 201–4. PMID 12175512.
  • Reynolds SD, Reynolds PR, Pryhuber GS; et al. (2003). "Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways". Am. J. Respir. Crit. Care Med. 166 (11): 1498–509. doi:10.1164/rccm.200204-285OC. PMID 12406855.
  • Niimi T, Copeland NG, Gilbert DJ; et al. (2003). "Cloning, expression, and chromosomal localization of the mouse gene (Scgb3a1, alias Ugrp2) that encodes a member of the novel uteroglobin-related protein gene family". Cytogenet. Genome Res. 97 (1–2): 120–7. PMID 12438750.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Krop I, Maguire P, Lahti-Domenici J; et al. (2003). "Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors". Cancer Res. 63 (9): 2024–7. PMID 12727813.
  • Bin LH, Nielson LD, Liu X; et al. (2003). "Identification of uteroglobin-related protein 1 and macrophage scavenger receptor with collagenous structure as a lung-specific ligand-receptor pair". J. Immunol. 171 (2): 924–30. PMID 12847263.
  • Clark HF, Gurney AL, Abaya E; et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMID 12975309.
  • Fackler MJ, McVeigh M, Evron E; et al. (2004). "DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma". Int. J. Cancer. 107 (6): 970–5. doi:10.1002/ijc.11508. PMID 14601057.
  • Tisserand P, Fouquet C, Barrois M; et al. (2004). "Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors". Cancer Biol. Ther. 2 (5): 559–63. PMID 14614327.
  • Marchetti A, Barassi F, Martella C; et al. (2004). "Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome". Clin. Cancer Res. 10 (4): 1338–43. PMID 14977834.
  • Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMID 15340161.
  • Krop I, Player A, Tablante A; et al. (2005). "Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types". Mol. Cancer Res. 2 (9): 489–94. PMID 15383627.
  • Shigematsu H, Suzuki M, Takahashi T; et al. (2005). "Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies". Int. J. Cancer. 113 (4): 600–4. doi:10.1002/ijc.20622. PMID 15472908.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Krop I, Parker MT, Bloushtain-Qimron N; et al. (2005). "HIN-1, an inhibitor of cell growth, invasion, and AKT activation". Cancer Res. 65 (21): 9659–69. doi:10.1158/0008-5472.CAN-05-1663. PMID 16266985.
  • Yang Q, Kiernan CM, Tian Y; et al. (2007). "Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome". Clin. Cancer Res. 13 (11): 3191–7. doi:10.1158/1078-0432.CCR-06-2846. PMID 17545522.
  • Wu Q, Lothe RA, Ahlquist T; et al. (2007). "DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets". Mol. Cancer. 6: 45. doi:10.1186/1476-4598-6-45. PMID 17623056.

Template:WikiDoc Sources